Nurix Therapeutics Overview
Nurix Therapeutics Target Price
Analysts' 12-month price predictions for NRIX.
Get informed when a big investor buys or sells
+ FollowShare Price
$22.98
Average Target Price
$33.45
45.6% upside
45.6% upside11 analysts in the last 4 months
High: $45 | Low: $23
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-10 | RBC Capital | $33 | 43.6% upside |  |
| 2026-07-10 | Truist FinancialGregory Renza | $34 | 48% upside | |
| 2026-07-10 | Stifel Nicolaus | $40 | 74.1% upside | |
| 2026-07-10 | H.C. Wainwright | $34 | 48% upside | |
| 2026-06-18 | Robert W. Baird | $33 | 43.6% upside | |
| 2026-06-09 | UBSDavid Dai | $23 | 0.1% upside | |
| 2026-06-09 | BTIGJeet Mukherjee | $32 | 39.3% upside | |
| 2026-06-08 | Truist Financial | $32 | 39.3% upside | |
| 2026-06-08 | JefferiesRoger Song | $45 | 95.8% upside | |
| 2026-06-08 | Needham | $34 | 48% upside | |
| 2026-04-09 | Wells Fargo | $28 | 21.8% upside | |
| 2026-01-29 | Stifel Nicolaus | $35 | 52.3% upside | |
| 2026-01-29 | Wells FargoDerek Archila | $29 | 26.2% upside | |
| 2026-01-29 | H.C. Wainwright | $32 | 39.3% upside | |
| 2026-01-08 | Morgan Stanley | $36 | 56.7% upside | |
| 2025-12-10 | H.C. WainwrightRobert Burns | $31 | 34.9% upside | |
| 2025-12-09 | BTIG | $30 | 30.5% upside | |
| 2025-11-24 | Truist Financial | $30 | 30.5% upside | |
| 2025-10-28 | H.C. Wainwright | $28 | 21.8% upside | |
| 2025-10-23 | BTIG | $27 | 17.5% upside | |
| 2025-10-23 | Wells Fargo | $21 |  8.6% downside | |
| 2025-10-22 | RBC CapitalGregory Renza | $29 | 26.2% upside | |
| 2025-10-14 | H.C. Wainwright | $33 | 43.6% upside | |
| 2025-10-13 | Wells Fargo | $22 | 4.3% downside | |
| 2025-10-10 | Stifel Nicolaus | $33 | 43.6% upside | |
| 2025-10-10 | OppenheimerMatthew Biegler | $28 | 21.8% upside | |
| 2025-10-10 | Piper Sandler | $32 | 39.3% upside | |
| 2025-07-15 | Morgan StanleyTerence Flynn | $16 | 30.4% downside | |
| 2025-07-10 | OppenheimerMatthew Biegler | $30 | 30.5% upside | |
| 2025-03-17 | Leerink Partners | $16 | 30.4% downside | |
| 2025-02-03 | Morgan StanleyTerence Flynn | $17 | 26% downside | |
| 2024-12-05 | BMO CapitalEtzer Darout | $35 | 52.3% upside | |
| 2024-10-24 | UBSDavid Dai | $35 | 52.3% upside | |
| 2024-10-21 | H.C. WainwrightRobert Burns | $30 | 30.5% upside | |
| 2024-10-15 | OppenheimerMatthew Biegler | $35 | 52.3% upside | |
| 2024-10-15 | Wells FargoDerek Archila | $32 | 39.3% upside | |
| 2024-10-14 | Stifel NicolausStephen Willey | $34 | 48% upside | |
| 2024-10-11 | JefferiesRoger Song | $41 | 78.4% upside | |
| 2024-09-05 | Robert W. BairdBrian Skorney | $26 | 13.1% upside | |
| 2024-08-14 | OppenheimerMatthew Biegler | $27 | 17.5% upside | |
| 2024-06-27 | RBC CapitalGregory Renza | $26 | 13.1% upside | |
| 2024-06-18 | H.C. WainwrightRobert Burns | $26 | 13.1% upside | |
| 2024-06-05 | Piper SandlerTyler Van Buren | $35 | 52.3% upside | |
| 2024-04-11 | RBC CapitalGregory Renza | $23 | 0.1% upside | |
| 2024-04-11 | Robert W. BairdJoel Beatty | $25 | 8.8% upside | |
| 2022-12-13 | Leerink Partners | $28 | 21.8% upside | |
| 2022-05-31 | Wells FargoDerek Archila | $25 | 8.8% upside | |